Refine
Year of publication
Document Type
- Article (18)
- Part of a Book (2)
- Book (1)
- Preprint (1)
Has Fulltext
- yes (22)
Is part of the Bibliography
- no (22)
Keywords
- Rheumatoid arthritis (2)
- animal (2)
- disease models (2)
- glioblastoma (2)
- hyperhomocysteinemia (2)
- vitamin B deficiency (2)
- ALL (1)
- AML (1)
- ARDS (1)
- Alzheimer’s disease (1)
- Anti-rheumatic agents (1)
- Atomic and Molecular Physics (1)
- COVID-19 (1)
- Chromosomal deletion (1)
- Congeneric species pairs (1)
- Critical care (1)
- Decision-making (1)
- Depression (1)
- EGFR (1)
- EGFRvIII mutation (1)
- Echium (1)
- Emotions (1)
- Erythema migrans (1)
- Galal-ad-Din Rumi (1)
- Hölderlin, Friedrich / Hyperion (1)
- Lyme borreliosis (1)
- MLL (1)
- Mental health and psychiatry (1)
- NSAIDs (1)
- Non-RCT (1)
- Outcome (1)
- PCR (1)
- Patient outcome assessment (1)
- Pharmacological treatment (1)
- Prognostic models (1)
- Psychometrics (1)
- Questionnaires (1)
- RCT (1)
- RNA, long noncoding (1)
- Rheumatology (1)
- Rückert, Friedrich (1)
- Skin manifestation (1)
- Systematic review (1)
- Tocilizumab (1)
- Treatment effectiveness (1)
- Verbascum (1)
- Wieland, Christoph Martin / Agathon (1)
- Zaimoglu, Feridun / Liebesmale, scharlachrot (1)
- acute leukemia (1)
- alzheimer disease (1)
- amyloid beta-peptides (1)
- chromosomal translocations (1)
- deletion 5q (1)
- epigenomics (1)
- hypertension, pulmonary (1)
- hypoxia (1)
- invasive vs. non-invasive species (1)
- local adaptation (1)
- memory and learning tests (1)
- myelodysplastic syndrome (1)
- native vs. exotic origins (1)
- neovascularization, physiologic (1)
- pre-adaptation (1)
- short tandem repeats (1)
- starvation (1)
- translocation partner genes (1)
- Ägäis <Motiv> (1)
- İzmir <Motiv> (1)
Institute
Background: Intensive Care Resources are heavily utilized during the COVID-19 pandemic. However, risk stratification and prediction of SARS-CoV-2 patient clinical outcomes upon ICU admission remain inadequate. This study aimed to develop a machine learning model, based on retrospective & prospective clinical data, to stratify patient risk and predict ICU survival and outcomes. Methods: A Germany-wide electronic registry was established to pseudonymously collect admission, therapeutic and discharge information of SARS-CoV-2 ICU patients retrospectively and prospectively. Machine learning approaches were evaluated for the accuracy and interpretability of predictions. The Explainable Boosting Machine approach was selected as the most suitable method. Individual, non-linear shape functions for predictive parameters and parameter interactions are reported. Results: 1039 patients were included in the Explainable Boosting Machine model, 596 patients retrospectively collected, and 443 patients prospectively collected. The model for prediction of general ICU outcome was shown to be more reliable to predict “survival”. Age, inflammatory and thrombotic activity, and severity of ARDS at ICU admission were shown to be predictive of ICU survival. Patients’ age, pulmonary dysfunction and transfer from an external institution were predictors for ECMO therapy. The interaction of patient age with D-dimer levels on admission and creatinine levels with SOFA score without GCS were predictors for renal replacement therapy. Conclusions: Using Explainable Boosting Machine analysis, we confirmed and weighed previously reported and identified novel predictors for outcome in critically ill COVID-19 patients. Using this strategy, predictive modeling of COVID-19 ICU patient outcomes can be performed overcoming the limitations of linear regression models. Trial registration “ClinicalTrials” (clinicaltrials.gov) under NCT04455451.
Bipolar disorder (BD) is a genetically complex mental illness characterized by severe oscillations of mood and behavior. Genome-wide association studies (GWAS) have identified several risk loci that together account for a small portion of the heritability. To identify additional risk loci, we performed a two-stage meta-analysis of >9 million genetic variants in 9,784 bipolar disorder patients and 30,471 controls, the largest GWAS of BD to date. In this study, to increase power we used ~2,000 lithium-treated cases with a long-term diagnosis of BD from the Consortium on Lithium Genetics, excess controls, and analytic methods optimized for markers on the Xchromosome. In addition to four known loci, results revealed genome-wide significant associations at two novel loci: an intergenic region on 9p21.3 (rs12553324, p = 5.87×10-9; odds ratio = 1.12) and markers within ERBB2 (rs2517959, p = 4.53×10-9; odds ratio = 1.13). No significant X-chromosome associations were detected and X-linked markers explained very little BD heritability. The results add to a growing list of common autosomal variants involved in BD and illustrate the power of comparing well-characterized cases to an excess of controls in GWAS.
Background Endothelium-derived nitric oxide plays an important role for the bone marrow microenvironment. Since several important effects of nitric oxide are mediated by cGMP-dependent pathways, we investigated the role of the cGMP downstream effector cGMP-dependent protein kinase I (cGKI) on postnatal neovascularization. Methodology/Principal Findings In a disc neovascularization model, cGKI -/- mice showed an impaired neovascularization as compared to their wild-type (WT) littermates. Infusion of WT, but not cGKI -/- bone marrow progenitors rescued the impaired ingrowth of new vessels in cGKI-deficient mice. Bone marrow progenitors from cGKI -/- mice showed reduced proliferation and survival rates. In addition, we used cGKI alpha leucine zipper mutant (LZM) mice as model for cGKI deficiency. LZM mice harbor a mutation in the cGKI alpha leucine zipper that prevents interaction with downstream signaling molecules. Consistently, LZM mice exhibited reduced numbers of vasculogenic progenitors and impaired neovascularization following hindlimb ischemia compared to WT mice. Conclusions/Significance Our findings demonstrate that the cGMP-cGKI pathway is critical for postnatal neovascularization and establish a new role for cGKI in vasculogenesis, which is mediated by bone marrow-derived progenitors.
Hyperhomocysteinemia has been suggested potentially to contribute to a variety of pathologies, such as Alzheimer’s disease (AD). While the impact of hyperhomocysteinemia on AD has been investigated extensively, there are scarce data on the effect of AD on hyperhomocysteinemia. The aim of this in vivo study was to investigate the kinetics of homocysteine (HCys) and homocysteic acid (HCA) and effects of AD-like pathology on the endogenous levels. The mice received a B-vitamin deficient diet for eight weeks, followed by the return to a balanced control diet for another eight weeks. Serum, urine, and brain tissues of AppNL-G-F knock-in and C57BL/6J wild type mice were analyzed for HCys and HCA using LC-MS/MS methods. Hyperhomocysteinemic levels were found in wild type and knock-in mice due to the consumption of the deficient diet for eight weeks, followed by a rapid normalization of the levels after the return to control chow. Hyperhomocysteinemic AppNL-G-F mice had significantly higher HCys in all matrices, but not HCA, compared to wild type control. Higher serum concentrations were associated with elevated levels in both the brain and in urine. Our findings confirm a significant impact of AD-like pathology on hyperhomocysteinemia in the AppNL-G-F mouse model. The immediate normalization of HCys and HCA after the supply of B-vitamins strengthens the idea of a B-vitamin intervention as a potentially preventive treatment option for HCys-related disorders such as AD.
Background: The epidermal growth factor receptor (EGFR) signaling pathway is genetically activated in approximately 50% of glioblastomas (GBs). Its inhibition has been explored clinically but produced disappointing results, potentially due to metabolic effects that protect GB cells against nutrient deprivation and hypoxia. Here, we hypothesized that EGFR activation could disable metabolic adaptation and define a GB cell population sensitive to starvation.
Methods: Using genetically engineered GB cells to model different types of EGFR activation, we analyzed changes in metabolism and cell survival under conditions of the tumor microenvironment.
Results: We found that expression of mutant EGFRvIII as well as EGF stimulation of EGFR-overexpressing cells impaired physiological adaptation to starvation and rendered cells sensitive to hypoxia-induced cell death. This was preceded by adenosine triphosphate (ATP) depletion and an increase in glycolysis. Furthermore, EGFRvIII mutant cells had higher levels of mitochondrial superoxides potentially due to decreased metabolic flux into the serine synthesis pathway which was associated with a decrease in the NADPH/NADP+ ratio.
Conclusions: The finding that EGFR activation renders GB cells susceptible to starvation could help to identify a subgroup of patients more likely to benefit from starvation-inducing therapies.
Die folgenden Ausführungen beleuchten anhand ausgewählter Beispiele die Art und Weise, wie Smyrna/Izmir, die Ägäis und "Kleinasien" in der deutschen Literatur dargestellt werden. Sie stehen damit zunächst im Kontext der Imagologie, die sie aber im Sinne einer kritischen interkulturellen Literaturwissenschaft erweitern. Denn es geht hier nicht (nur) darum, "Bilder" des ägäischen Raums und seiner Metropole nachzuzeichnen, sondern der Frage nachzugehen, wie die Diskurse über den fremden Ort und die fremde Region mit Fragen und Problemen des Eigenen, des Deutschen, zusammenhängen, das heißt, welche Funktion die Bilder des Fremden im Hinblick auf das Eigene haben. Die Stichproben, die ich vornehme, bezieht sich nach einem kurzen Blick auf Wielands 'Agathon' (erste Fassung 1766/67), den wichtigsten Roman der deutschen Aufklärung, zunächst vornehmlich auf Hölderlins 'Hyperion' (1797/99). Weder Wieland noch Hölderlin […] haben […] das Objekt ihrer Beschreibung niemals in Augenschein nehmen können. Insofern ist klar, dass vor allem das Bild Wieland auf Stereotypen beruht, die aber ihrerseits von einem nicht unerheblichen Interesse sind. Wie wir zeigen werden, ist Hölderlin mehr als Wieland auf eine solide Dokumentation bedacht, und er schöpft aus zeitgenössischen Reiseberichten, zumal er ja nicht wie Wieland das antike Smyrna, sondern das Smyrna/Izmir seiner Epoche darstellt. Als reizvollen Kontrast zu den Klassikern der deutschen Literatur wenden wir uns dann Feridun Zaimoglu zu, dem "Star" und enfant terrible der deutsch-türkischen Gegenwartsliteratur, der in seinem Roman 'Liebesmale scharlachrot' (2000) seinen Protagonisten Serdar von Kiel an die türkische Ägäisküste versetzt. Dabei ist sowohl beim Protagonisten als auch beim Autor die Konstellation Eigenes-Fremdes in Bezug auf die Ägäis und die Region komplex, denn für beide ist die Türkei und damit auch "Kleinasien" fremd und eigen zugleich: Sie sind nämlich in Deutschland aufgewachsen und eher mit den deutschen Verhältnissen vertraut und kommen einerseits durchaus als Fremde in das Land ihrer Vorfahren, dem sie dennoch in spezifischer Weise verbunden sind.
The article shows that Heinrich Rückert is one of the most interesting voices within the corpus of texts showing German encounters with Islam in the 19th century. While actual reflections on the European and American relation to Islam are largely influenced by a point of view stressing a “Clash of Civilisations” (Samuel Huntington), especially after 9/11, Rückert's occupation with the texts and poems of Mevlana Rumi shows that the humanistic and poetic implications of Rumi’s work helped Rückert to find a poetic language that placed itself in the tradition of Goethes’s “West-östlicher Divan” and a German pantheism that is to be seen in the context of the “Spinoza renaissance” at the beginning of the 19th century. Islamic culture is in Rückert’s work a part of the heritage of mankind and of a humanism that goes far beyond the limits of eurocentrism.
Background: Erythema migrans represents an early cutaneous and most common manifestation of Lyme borreliosis. Recommendations regarding pharmacological agents, dose and duration of treatment are subject of intense debate. This review aims to explore differences in efficacy and safety between pharmacological treatments and control treatment.
Methods: To identify relevant studies, we will conduct a systematic literature search. We will include randomised controlled trials (RCTs) and non-RCTs. Eligible comparative studies need to (1) consider patients with a diagnosis of erythema migrans resulting from Lyme borreliosis and (2) compare different pharmacological agents against each other, against any other non-pharmacological treatment, placebo or no treatment. Two review authors will independently assess included studies for risk of bias according to the methods of the Cochrane Handbook for Systematic Reviews of Interventions and related to specific study designs. We will address patient-relevant outcomes including clinical remission of cutaneous symptoms, any treatment-related adverse events, quality of life and progressive symptoms such as neuroborreliosis or Lyme carditis and flu-like symptoms. Provided that the identified trials are comparable in terms of clinical issues, combined estimates will be provided. Estimations of treatment effects will be calculated based on a random effects model. Heterogeneity will be evaluated based on I (2) and chi-square test. In case of significant heterogeneity, a pooled estimate will not be provided, but heterogeneity will be investigated on the basis of methodological and clinical study aspects. We plan subgroup analysis to reveal potential differences in the effect estimates between patient populations and treatment specifications. We will consider risk of bias using sensitivity analyses to decide whether to rely on the pooled estimates. The quality of a body of evidence for individual outcomes will be assessed using the GRADE approach.
Discussion: Benefits and harms of pharmacological treatment in erythema migrans have not yet been adequately assessed. This systematic review will evaluate and summarise available evidence addressing benefits and harms of different pharmacological treatments. In addition, this summary of clinical evidence will inform decision-making between clinicians and patients and will play an important part in patient care.
Systematic review registration: PROSPERO: CRD42016037932.
Background: Hyperhomocysteinemia is considered a possible contributor to the complex pathology of Alzheimer’s disease (AD). For years, researchers in this field have discussed the apparent detrimental effects of the endogenous amino acid homocysteine in the brain. In this study, the roles of hyperhomocysteinemia driven by vitamin B deficiency, as well as potentially beneficial dietary interventions, were investigated in the novel AppNL-G-F knock-in mouse model for AD, simulating an early stage of the disease. Methods: Urine and serum samples were analyzed using a validated LC-MS/MS method and the impact of different experimental diets on cognitive performance was studied in a comprehensive behavioral test battery. Finally, we analyzed brain samples immunohistochemically in order to assess amyloid-β (Aβ) plaque deposition. Results: Behavioral testing data indicated subtle cognitive deficits in AppNL-G-F compared to C57BL/6J wild type mice. Elevation of homocysteine and homocysteic acid, as well as counteracting dietary interventions, mostly did not result in significant effects on learning and memory performance, nor in a modified Aβ plaque deposition in 35-week-old AppNL-G-F mice. Conclusion: Despite prominent Aβ plaque deposition, the AppNL-G-F model merely displays a very mild AD-like phenotype at the investigated age. Older AppNL-G-F mice should be tested in order to further investigate potential effects of hyperhomocysteinemia and dietary interventions.